BMC Infect Dis:轮状病毒疫苗可减少严重轮状病毒感染的发生率

2020-11-08 MedSci原创 MedSci原创

人类A组轮状病毒是全球幼儿严重急性肠胃炎的主要原因。免疫接种计划减少了许多国家的疾病负担。因为轮状病毒疫苗不受国家卫生系统的资助,西班牙巴伦西亚自治区的疫苗接种覆盖率约为40%。尽管疫苗覆盖率处于中等

人类A组轮状病毒是全球幼儿严重急性肠胃炎的主要原因。免疫接种计划减少了许多国家的疾病负担。因为轮状病毒疫苗不受国家卫生系统的资助,西班牙巴伦西亚自治区的疫苗接种覆盖率约为40%。尽管疫苗覆盖率处于中等偏下水平,但轮状病毒疫苗接种还是大大降低了因轮状病毒感染而导致的住院率和医院相关费用。然而,很少有研究评估接种疫苗的儿童不需要住院的症状性轮状病毒感染。本研究旨在调查2013年至2015年西班牙瓦伦西亚大学Clínico医院所服务的卫生区域内接种疫苗儿童的症状性轮状病毒感染情况。
共纳入133名年龄小于5岁的轮状病毒感染儿童。收集了人口统计学和流行病学数据,并获得了其看护人的知情同意。按照EuroRotaNet网络的标准程序,通过免疫学方法检测轮状病毒感染,并通过RT-PCR测定G/P轮状病毒基因型。
 
结果,133名婴儿中有40名婴儿(30.1%;95%CI:22.3-37.9)被诊断为有症状的轮状病毒感染,尽管他们以前曾接种过RotaTeq(85%)或Rotarix(15%)疫苗。完全接种轮状病毒疫苗的儿童(24.8%)、部分接种的儿童(5.3%)和未接种的儿童(69.9%)。感染基因型表现出较高的G型多样性,但同期感染接种疫苗和未接种疫苗儿童的G/P基因型之间未发现显著差异。G9P[8]、G12P[8]和G1P[8]是最流行的基因型。28名(66.6%)接种疫苗的儿童和67名(73.6%)未接种疫苗的儿童胃肠炎症状严重需要到急诊室就诊。
综上所述,该研究结果表,轮状病毒疫苗在减少严重轮状病毒感染的发生率方面的功效已经得到了充分的证明,但疫苗接种者有时会出现轮状病毒感染的症状。
 
原始出处:
Raúl Pérez-Ortín, Cristina Santiso-Bellón, et al., Rotavirus symptomatic infection among unvaccinated and vaccinated children in Valencia, Spain. BMC Infect Dis. 2019 Nov 27;19(1):998.  doi: 10.1186/s12879-019-4550-x.

版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (6)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=2013519, encodeId=3e07201351919, content=<a href='/topic/show?id=7d69598468' target=_blank style='color:#2F92EE;'>#Dis#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=39, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=5984, encryptionId=7d69598468, topicName=Dis)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4c37265, createdName=zhaojie88, createdTime=Mon Aug 02 04:19:54 CST 2021, time=2021-08-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1826646, encodeId=3532182664684, content=<a href='/topic/show?id=e5283e89970' target=_blank style='color:#2F92EE;'>#发生率#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=37899, encryptionId=e5283e89970, topicName=发生率)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=30bd35, createdName=一叶知秋, createdTime=Fri Sep 10 20:19:54 CST 2021, time=2021-09-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1975037, encodeId=8a5f19e503702, content=<a href='/topic/show?id=f145355379' target=_blank style='color:#2F92EE;'>#BMC#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=3553, encryptionId=f145355379, topicName=BMC)], attachment=null, authenticateStatus=null, createdAvatar=https://thirdqq.qlogo.cn/qqapp/101173734/363C99735735B7F4CB11D5F78F580525/100, createdBy=aab22500211, createdName=ms3025846204744509, createdTime=Fri Apr 23 05:19:54 CST 2021, time=2021-04-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2083339, encodeId=9e9120833390c, content=<a href='/topic/show?id=b7cce09742a' target=_blank style='color:#2F92EE;'>#病毒疫苗#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=42, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=70974, encryptionId=b7cce09742a, topicName=病毒疫苗)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1dbc2500219, createdName=huagfeg, createdTime=Sat Apr 17 09:19:54 CST 2021, time=2021-04-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1372784, encodeId=de2513e27842b, content=<a href='/topic/show?id=ee2b9348928' target=_blank style='color:#2F92EE;'>#轮状病毒#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=39, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=93489, encryptionId=ee2b9348928, topicName=轮状病毒)], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=47c5349, createdName=tastas, createdTime=Mon Nov 09 16:19:54 CST 2020, time=2020-11-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1623648, encodeId=f24916236482c, content=<a href='/topic/show?id=2c139349126' target=_blank style='color:#2F92EE;'>#轮状病毒疫苗#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=38, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=93491, encryptionId=2c139349126, topicName=轮状病毒疫苗)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=617520580162, createdName=tulenzi, createdTime=Mon Nov 09 16:19:54 CST 2020, time=2020-11-09, status=1, ipAttribution=)]
    2021-08-02 zhaojie88
  2. [GetPortalCommentsPageByObjectIdResponse(id=2013519, encodeId=3e07201351919, content=<a href='/topic/show?id=7d69598468' target=_blank style='color:#2F92EE;'>#Dis#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=39, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=5984, encryptionId=7d69598468, topicName=Dis)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4c37265, createdName=zhaojie88, createdTime=Mon Aug 02 04:19:54 CST 2021, time=2021-08-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1826646, encodeId=3532182664684, content=<a href='/topic/show?id=e5283e89970' target=_blank style='color:#2F92EE;'>#发生率#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=37899, encryptionId=e5283e89970, topicName=发生率)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=30bd35, createdName=一叶知秋, createdTime=Fri Sep 10 20:19:54 CST 2021, time=2021-09-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1975037, encodeId=8a5f19e503702, content=<a href='/topic/show?id=f145355379' target=_blank style='color:#2F92EE;'>#BMC#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=3553, encryptionId=f145355379, topicName=BMC)], attachment=null, authenticateStatus=null, createdAvatar=https://thirdqq.qlogo.cn/qqapp/101173734/363C99735735B7F4CB11D5F78F580525/100, createdBy=aab22500211, createdName=ms3025846204744509, createdTime=Fri Apr 23 05:19:54 CST 2021, time=2021-04-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2083339, encodeId=9e9120833390c, content=<a href='/topic/show?id=b7cce09742a' target=_blank style='color:#2F92EE;'>#病毒疫苗#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=42, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=70974, encryptionId=b7cce09742a, topicName=病毒疫苗)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1dbc2500219, createdName=huagfeg, createdTime=Sat Apr 17 09:19:54 CST 2021, time=2021-04-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1372784, encodeId=de2513e27842b, content=<a href='/topic/show?id=ee2b9348928' target=_blank style='color:#2F92EE;'>#轮状病毒#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=39, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=93489, encryptionId=ee2b9348928, topicName=轮状病毒)], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=47c5349, createdName=tastas, createdTime=Mon Nov 09 16:19:54 CST 2020, time=2020-11-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1623648, encodeId=f24916236482c, content=<a href='/topic/show?id=2c139349126' target=_blank style='color:#2F92EE;'>#轮状病毒疫苗#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=38, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=93491, encryptionId=2c139349126, topicName=轮状病毒疫苗)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=617520580162, createdName=tulenzi, createdTime=Mon Nov 09 16:19:54 CST 2020, time=2020-11-09, status=1, ipAttribution=)]
  3. [GetPortalCommentsPageByObjectIdResponse(id=2013519, encodeId=3e07201351919, content=<a href='/topic/show?id=7d69598468' target=_blank style='color:#2F92EE;'>#Dis#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=39, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=5984, encryptionId=7d69598468, topicName=Dis)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4c37265, createdName=zhaojie88, createdTime=Mon Aug 02 04:19:54 CST 2021, time=2021-08-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1826646, encodeId=3532182664684, content=<a href='/topic/show?id=e5283e89970' target=_blank style='color:#2F92EE;'>#发生率#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=37899, encryptionId=e5283e89970, topicName=发生率)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=30bd35, createdName=一叶知秋, createdTime=Fri Sep 10 20:19:54 CST 2021, time=2021-09-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1975037, encodeId=8a5f19e503702, content=<a href='/topic/show?id=f145355379' target=_blank style='color:#2F92EE;'>#BMC#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=3553, encryptionId=f145355379, topicName=BMC)], attachment=null, authenticateStatus=null, createdAvatar=https://thirdqq.qlogo.cn/qqapp/101173734/363C99735735B7F4CB11D5F78F580525/100, createdBy=aab22500211, createdName=ms3025846204744509, createdTime=Fri Apr 23 05:19:54 CST 2021, time=2021-04-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2083339, encodeId=9e9120833390c, content=<a href='/topic/show?id=b7cce09742a' target=_blank style='color:#2F92EE;'>#病毒疫苗#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=42, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=70974, encryptionId=b7cce09742a, topicName=病毒疫苗)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1dbc2500219, createdName=huagfeg, createdTime=Sat Apr 17 09:19:54 CST 2021, time=2021-04-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1372784, encodeId=de2513e27842b, content=<a href='/topic/show?id=ee2b9348928' target=_blank style='color:#2F92EE;'>#轮状病毒#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=39, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=93489, encryptionId=ee2b9348928, topicName=轮状病毒)], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=47c5349, createdName=tastas, createdTime=Mon Nov 09 16:19:54 CST 2020, time=2020-11-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1623648, encodeId=f24916236482c, content=<a href='/topic/show?id=2c139349126' target=_blank style='color:#2F92EE;'>#轮状病毒疫苗#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=38, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=93491, encryptionId=2c139349126, topicName=轮状病毒疫苗)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=617520580162, createdName=tulenzi, createdTime=Mon Nov 09 16:19:54 CST 2020, time=2020-11-09, status=1, ipAttribution=)]
  4. [GetPortalCommentsPageByObjectIdResponse(id=2013519, encodeId=3e07201351919, content=<a href='/topic/show?id=7d69598468' target=_blank style='color:#2F92EE;'>#Dis#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=39, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=5984, encryptionId=7d69598468, topicName=Dis)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4c37265, createdName=zhaojie88, createdTime=Mon Aug 02 04:19:54 CST 2021, time=2021-08-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1826646, encodeId=3532182664684, content=<a href='/topic/show?id=e5283e89970' target=_blank style='color:#2F92EE;'>#发生率#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=37899, encryptionId=e5283e89970, topicName=发生率)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=30bd35, createdName=一叶知秋, createdTime=Fri Sep 10 20:19:54 CST 2021, time=2021-09-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1975037, encodeId=8a5f19e503702, content=<a href='/topic/show?id=f145355379' target=_blank style='color:#2F92EE;'>#BMC#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=3553, encryptionId=f145355379, topicName=BMC)], attachment=null, authenticateStatus=null, createdAvatar=https://thirdqq.qlogo.cn/qqapp/101173734/363C99735735B7F4CB11D5F78F580525/100, createdBy=aab22500211, createdName=ms3025846204744509, createdTime=Fri Apr 23 05:19:54 CST 2021, time=2021-04-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2083339, encodeId=9e9120833390c, content=<a href='/topic/show?id=b7cce09742a' target=_blank style='color:#2F92EE;'>#病毒疫苗#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=42, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=70974, encryptionId=b7cce09742a, topicName=病毒疫苗)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1dbc2500219, createdName=huagfeg, createdTime=Sat Apr 17 09:19:54 CST 2021, time=2021-04-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1372784, encodeId=de2513e27842b, content=<a href='/topic/show?id=ee2b9348928' target=_blank style='color:#2F92EE;'>#轮状病毒#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=39, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=93489, encryptionId=ee2b9348928, topicName=轮状病毒)], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=47c5349, createdName=tastas, createdTime=Mon Nov 09 16:19:54 CST 2020, time=2020-11-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1623648, encodeId=f24916236482c, content=<a href='/topic/show?id=2c139349126' target=_blank style='color:#2F92EE;'>#轮状病毒疫苗#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=38, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=93491, encryptionId=2c139349126, topicName=轮状病毒疫苗)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=617520580162, createdName=tulenzi, createdTime=Mon Nov 09 16:19:54 CST 2020, time=2020-11-09, status=1, ipAttribution=)]
  5. [GetPortalCommentsPageByObjectIdResponse(id=2013519, encodeId=3e07201351919, content=<a href='/topic/show?id=7d69598468' target=_blank style='color:#2F92EE;'>#Dis#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=39, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=5984, encryptionId=7d69598468, topicName=Dis)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4c37265, createdName=zhaojie88, createdTime=Mon Aug 02 04:19:54 CST 2021, time=2021-08-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1826646, encodeId=3532182664684, content=<a href='/topic/show?id=e5283e89970' target=_blank style='color:#2F92EE;'>#发生率#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=37899, encryptionId=e5283e89970, topicName=发生率)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=30bd35, createdName=一叶知秋, createdTime=Fri Sep 10 20:19:54 CST 2021, time=2021-09-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1975037, encodeId=8a5f19e503702, content=<a href='/topic/show?id=f145355379' target=_blank style='color:#2F92EE;'>#BMC#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=3553, encryptionId=f145355379, topicName=BMC)], attachment=null, authenticateStatus=null, createdAvatar=https://thirdqq.qlogo.cn/qqapp/101173734/363C99735735B7F4CB11D5F78F580525/100, createdBy=aab22500211, createdName=ms3025846204744509, createdTime=Fri Apr 23 05:19:54 CST 2021, time=2021-04-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2083339, encodeId=9e9120833390c, content=<a href='/topic/show?id=b7cce09742a' target=_blank style='color:#2F92EE;'>#病毒疫苗#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=42, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=70974, encryptionId=b7cce09742a, topicName=病毒疫苗)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1dbc2500219, createdName=huagfeg, createdTime=Sat Apr 17 09:19:54 CST 2021, time=2021-04-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1372784, encodeId=de2513e27842b, content=<a href='/topic/show?id=ee2b9348928' target=_blank style='color:#2F92EE;'>#轮状病毒#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=39, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=93489, encryptionId=ee2b9348928, topicName=轮状病毒)], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=47c5349, createdName=tastas, createdTime=Mon Nov 09 16:19:54 CST 2020, time=2020-11-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1623648, encodeId=f24916236482c, content=<a href='/topic/show?id=2c139349126' target=_blank style='color:#2F92EE;'>#轮状病毒疫苗#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=38, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=93491, encryptionId=2c139349126, topicName=轮状病毒疫苗)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=617520580162, createdName=tulenzi, createdTime=Mon Nov 09 16:19:54 CST 2020, time=2020-11-09, status=1, ipAttribution=)]
  6. [GetPortalCommentsPageByObjectIdResponse(id=2013519, encodeId=3e07201351919, content=<a href='/topic/show?id=7d69598468' target=_blank style='color:#2F92EE;'>#Dis#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=39, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=5984, encryptionId=7d69598468, topicName=Dis)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4c37265, createdName=zhaojie88, createdTime=Mon Aug 02 04:19:54 CST 2021, time=2021-08-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1826646, encodeId=3532182664684, content=<a href='/topic/show?id=e5283e89970' target=_blank style='color:#2F92EE;'>#发生率#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=37899, encryptionId=e5283e89970, topicName=发生率)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=30bd35, createdName=一叶知秋, createdTime=Fri Sep 10 20:19:54 CST 2021, time=2021-09-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1975037, encodeId=8a5f19e503702, content=<a href='/topic/show?id=f145355379' target=_blank style='color:#2F92EE;'>#BMC#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=3553, encryptionId=f145355379, topicName=BMC)], attachment=null, authenticateStatus=null, createdAvatar=https://thirdqq.qlogo.cn/qqapp/101173734/363C99735735B7F4CB11D5F78F580525/100, createdBy=aab22500211, createdName=ms3025846204744509, createdTime=Fri Apr 23 05:19:54 CST 2021, time=2021-04-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2083339, encodeId=9e9120833390c, content=<a href='/topic/show?id=b7cce09742a' target=_blank style='color:#2F92EE;'>#病毒疫苗#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=42, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=70974, encryptionId=b7cce09742a, topicName=病毒疫苗)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1dbc2500219, createdName=huagfeg, createdTime=Sat Apr 17 09:19:54 CST 2021, time=2021-04-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1372784, encodeId=de2513e27842b, content=<a href='/topic/show?id=ee2b9348928' target=_blank style='color:#2F92EE;'>#轮状病毒#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=39, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=93489, encryptionId=ee2b9348928, topicName=轮状病毒)], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=47c5349, createdName=tastas, createdTime=Mon Nov 09 16:19:54 CST 2020, time=2020-11-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1623648, encodeId=f24916236482c, content=<a href='/topic/show?id=2c139349126' target=_blank style='color:#2F92EE;'>#轮状病毒疫苗#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=38, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=93491, encryptionId=2c139349126, topicName=轮状病毒疫苗)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=617520580162, createdName=tulenzi, createdTime=Mon Nov 09 16:19:54 CST 2020, time=2020-11-09, status=1, ipAttribution=)]

相关资讯

世卫组织:尚无证据表明貂体内变异新冠病毒会影响疫苗效果

世界卫生组织专家6日表示,目前尚无证据表明丹麦最新出现的感染养殖貂的变异新冠病毒会影响未来新冠疫苗的效果。

Nat Biomed Eng:**“打击”白血病!中国科学家开发出新型治疗性白血病疫苗

作为血液系统恶性肿瘤之一,白血病严重威胁了人类的健康。虽然常规化学疗法取得了进步,但许多患者仍然面临棘手的问题,包括严重的毒性反应和对化学疗法的不敏感性。最近,免疫疗法已成为治疗白血病的新突破。

Lancet:植物基4价流感疫苗的有效性研究

植物基四价流感疫苗对65岁老年人群流感样疾病的预防效果与四价灭活疫苗相当,且耐受性良好

宝贝黄疸可以接种疫苗吗?

黄疸只是一种症状学上的诊断,它不是一种疾病。婴儿黄疸是婴儿期最常见的临床症状,主要是由于胆红素在体内积累而引起的皮肤、黏膜或其他器官黄染。

英国MHRA开始对Moderna新冠病毒疫苗进行滚动审查

mRNA-1273第一阶段研究中期分析结果显示,接受两剂疫苗的参与者对SARS-CoV-2具有快速且强烈的免疫反应。

世行前行长、世卫组织原总干事顾问金墉:用团结合作助力全球公共卫生发展

2020年10月24日,第二届世界中医药互联网产业大会(WCIICM2020)在济南盛大开幕。大会以“扁鹊故里?康养济南——后疫情时代的中医药互联网大健康事业产业发